Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
UHN's 2010 Inventor of the Year Award was presented to Dr. Gang Zheng, Senior Scientist, OCI, at the AGM reception on June 15.
The award, sponsored through UHN's Technology Development and Commercialization Office, is presented to a UHN researcher who has made an outstanding and inventive contribution to patient-oriented biomedical research.
Dr. Zheng's research focus involves the creation of a unique organic nanoparticle delivery platform capable of transporting cancer therapeutics directly to tumours. This technology has the potential to reduce side effects in patients due to the biocompatible nature of the nanocarriers and the targeted delivery of the drugs. UHN, in collaboration with the Ontario Institute for Cancer Research (OICR), has recently formed a Toronto-based biotechnology company called DLVR Therapeutics Incorporated, to rapidly advance the commercialization of this technology for the benefit of patients in Ontario and around the world. Dr. Zheng recently developed a new class of nanoparticles, called porphysomes, which convert light to heat in an energy efficient manner. When accumulated in tumours, porphysomes converted light from a laser and successfully destroyed the tumours through photoablation.
Dr. Zheng holds the Joey and Toby Tanenbaum/Brazilian Ball Chair in prostate cancer research. His work is supported by national and international granting agencies such as the Canadian Institutes of Health Research, OICR, the Ministry of Research and Innovation, and the National Institutes of Health. His work has appeared in over 100 publications, including prestigious journals like Nature Materials and the Proceedings of the National Academy of Sciences.
Congratulations Dr. Zheng.